Skip Navigation

European Heart Journal 1995 16(Supplement L):68-74; doi:10.1093/eurheartj/16.suppl_L.68
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Knudtson, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knudtson, M. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Scociety of Cardiology

Clinical management of unstable angina: the place of antithrombins and platelet GP IIb/IIIa receptor blockers

M. L. Knudtson

University of Calgary

Correspondence: M. L. Knudtson, University of Calgary, Canada

Unstable angina is a clinical and anatomic mosaic in which platelet aggregation, thrombus formation and fixed and dynamic coronary artery restrictions play variable and changing roles Emerging medical and mechanical options to deal with each of these components show promise. GP IIb/IIIa receptor blockade is a significant advance over aspirin as all pathways to platelet aggregation are blocked by the new agents. Whether the new antithrombins represent a major advance over heparin is less clear as prothrombin activation is not blocked and rebound is seen as a result. For these new antiplatelet and antithrombin medications, encouragement is based upon small trials. The initial impressions need to be confirmed in larger trials before the role of these expensive new agents can be defined.

Key Words: Unstable angina • antiplatelet • antithrombin • glycoprotein IIb/IIIa • angiography • heparin • aspirin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.